dbACP: A Comprehensive Database of Anti-Cancer Peptides

9 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp02322 CCL21 SDGGAQDCCLKYSQRKIPAKVVRSYRKQEPSLGCSIPAILFLPRKRSQAELCADPKELWVQQLMQHLDKTPSPQKPAQGCRKDRGASKTGKKGKGSKGCKRTERSQTPKGP Human Disruption of membrane Not specified Not found Not found Not found
dbacp05487 Pexiganan acetate GIGKFLKKAKKFGKAFVKILKK Engineered Disruption of membrane permeability MTT/MTS assay U-937 Lymphoma cancer 75% Cytotoxicity at 0.5 µg/ml
dbacp05489 Pexiganan MSI-78 GIGKFLKKAKKFGKAFVKILKK Helical peptide with a predominance of one or more amino acids tryptophane-rich Disruption of membrane permeability MTT/MTS assay U-937 Lymphoma cancer 75% Cytotoxicity at 0.5 µg/ml
dbacp05561 Pis1 FIHHIIGWISHGVRAIHRAIH Atlantic cod Disruption of membrane Not specified Not found Not found Not found
dbacp05562 Pis2 FLHHIVGLIHHGLSLFGDRAD Atlantic cod Disruption of membrane Not specified Not found Not found Not found
dbacp06242 Temporin-1RNa ILPIRSLIKKLL The black-spotted frog, Northeastern China, Asia Disruption of membrane Cytotoxicity assay, MTT/MTS assay MCF 7 Breast cancer IC50 : 23.4 ± 5.2 µM
dbacp06243 Temporin-1RNa ILPIRSLIKKLL The black-spotted frog, Northeastern China, Asia Disruption of membrane Cytotoxicity assay, MTT/MTS assay HeLa Cervical carcinoma IC50 : 24.5 ± 3.8 µM
dbacp06244 Temporin-1RNb FLPLKKLRFGLL The black-spotted frog, Northeastern China, Asia Disruption of membrane Cytotoxicity assay, MTT/MTS assay MCF 7 Breast cancer IC50 : 11.4 ± 2.3 µM
dbacp06245 Temporin-1RNb FLPLKKLRFGLL The black-spotted frog, Northeastern China, Asia Disruption of membrane Cytotoxicity assay, MTT/MTS assay HeLa Cervical carcinoma IC50 : 12.8 ± 8.6 µM